A heretofore undisclosed crux of Eosinophilia-Myalgia Syndrome: compromised histamine degradation

@article{Smith2005AHU,
  title={A heretofore undisclosed crux of Eosinophilia-Myalgia Syndrome: compromised histamine degradation},
  author={M. Smith and R. H. Garrett},
  journal={Inflammation Research},
  year={2005},
  volume={54},
  pages={435-450}
}
  • M. Smith, R. H. Garrett
  • Published 2005
  • Chemistry, Medicine
  • Inflammation Research
    • Abstract.In contrast to early epidemiological evidence offering links between eosinophilia-myalgia syndrome (EMS) and microimpurities of L-tryptophan-containing dietary supplements (LTCDS), this account shows why reliance on a finite impurity from one manufacturer is both unnecessary and insufficient to explain the etiology of EMS. Excessive histamine activity has induced blood eosinophilia and myalgia (Greek: mys, muscle + algos, pain). Termination of the multiple actions of histamine is… CONTINUE READING
    View on Springer
    ncbi.nlm.nih.gov
    27 Citations
    Highly Influential Citations
    1
    Background Citations
    8
    27 Citations
    Citation Type

    Citation Type

    Part II. Eosinophilia-Myalgia Syndrome: further correlations between compromised histamine degradation, eosinophilias and myopathies
    • 1
    Mécanismes d’action indirects et mixtes mis en jeu dans les myopathies toxiques
    [Indirect and mixed mechanisms of action in toxic myopathies].
    Peak AAA fatty acid homolog contaminants present in the dietary supplement l-Tryptophan associated with the onset of eosinophilia-myalgia syndrome.
    • 2
    • PDF
    Histamine in food: is there anything to worry about?
    • 32
    • PDF
    The importance of NAD in multiple sclerosis.
    • 55
    • PDF
    Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes.
    • 370
    Drugs induced pulmonary arterial hypertension.
    • 30
    • PDF
    Effect of orally administered dipterinyl calcium pentahydrate on oral glucose tolerance in diet-induced obese mice
    • 2
    • PDF
    Food contamination.
    • 3

    References

    SHOWING 1-10 OF 359 REFERENCES
    Eosinophilia myalgia syndrome.
    • W. Blackburn
    • Medicine
    • Seminars in arthritis and rheumatism
    • 1997
    • 41
    Tryptophan produced by Showa Denko and epidemic eosinophilia-myalgia syndrome.
    • 44
    Myalgia and eosinophilia associated with ingestion of tryptophan. An intriguing new syndrome.
    • 2
    Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan.
    • 224
    An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use.
    • 296
    Hypodense eosinophils and interleukin 5 activity in the blood of patients with the eosinophilia-myalgia syndrome.
    • W. Owen, J. Petersen, +5 authors K. Austen
    • Biology, Medicine
    • Proceedings of the National Academy of Sciences of the United States of America
    • 1990
    • 87
    • Highly Influential
    • PDF
    Eosinophilia-Myalgia Syndrome not Associated with the Ingestion of Nutritional Supplements
    • 1
    • PDF
    Eosinophilia-myalgia syndrome or fibromyalgia with eosinophilia?
    • 10
    Idiopathic and L-tryptophan-associated eosinophilic fasciitis before and after L-tryptophan contamination.
    • 49
    The cause and pathogenesis of the eosinophilia-myalgia syndrome.
    • 20